Helix BioPharma Corp News - HBP

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP Canada NewsWire TORONTO, le...

Canadian Investment Regulatory Organization Trade Resumption - HBP

Canadian Investment Regulatory Organization Trade Resumption - HBP Canada NewsWire TORONTO, April 1, 2024 TORONTO, April 1, 2024 /CNW/ - Trading...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP Canada NewsWire TORONTO, le 28...

Canadian Investment Regulatory Organization Trading Halt - HBP

Canadian Investment Regulatory Organization Trading Halt - HBP Canada NewsWire TORONTO, March 28, 2024 TORONTO, March 28, 2024 /CNW/ - The...

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

RICHMOND HILL, Ontario, July 30, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an...

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

RICHMOND HILL, Ontario, July 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

RICHMOND HILL, Ontario, June 26, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) -- Proactive, the digital financial news organization, will be...

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

RICHMOND HILL, Ontario, June 11, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

Helix BioPharma Corp. Provides Corporate Update

RICHMOND HILL, Ontario, April 02, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (“Helix” or the...

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

RICHMOND HILL, Ontario, March 16, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), a an...

Helix BioPharma Corp. Closes $6.0 Million Private Placement

RICHMOND HILL, Ontario, March 12, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP)

Professional-Grade Tools, for Individual Investors.

HBP News

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP

Canadian Investment Regulatory Organization Trade Resumption - HBP

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP

Canadian Investment Regulatory Organization Trading Halt - HBP

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

Helix BioPharma Corp. Provides Corporate Update

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

Helix BioPharma Corp. Closes $6.0 Million Private Placement

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

HBP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP) News

Helix BioPharma Corp (HBP)

Professional-Grade Tools, for Individual Investors.

HBP News

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - HBP

Canadian Investment Regulatory Organization Trade Resumption - HBP

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - HBP

Canadian Investment Regulatory Organization Trading Halt - HBP

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

Helix BioPharma Corp. Provides Corporate Update

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

Helix BioPharma Corp. Closes $6.0 Million Private Placement

Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference

HBP Discussion

Your Recent History